A new study conducted by researchers at Intermountain Health in Salt Lake City has revealed a high number of patients diagnosed with heart failure who also have atrial fibrillation (AF), a co-occurrence that leads to significantly worse health outcomes. The study’s findings suggest that regular screening for AF in patients…

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA say they have engineered a novel experimental drug that may enhance heart repair following a heart attack, with the potential to reduce the incidence of heart failure in patients. The new drug, details…

A new, point-of-care, electrochemical biosensor that is similar to the lateral flow tests for COVID, can detect the presence of two heart failure biomarkers from a drop of saliva in as little as 15 minutes. The new non-invasive test could move vital screening from the lab to the home and…

A study led by the University of East Anglia (UEA) and Queen Mary University of London in the U.K. shows that the use of magnetic resonance imaging (MRI) to measure pressure in blood vessels around the heart is a good predictor of heart failure risk. The researchers report that higher…

Eli Lilly’s blockbuster diabetes and obesity drug tirzepatide has achieved good results in a Phase III trial of the medication in adults with heart failure with preserved ejection fraction and obesity. The company announced that the joint glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) agonist met its two primary…

Researchers at the Fujita Health University in Japan report that adding a measure of how well kidneys are filtering blood called estimated glomerular filtration rate (eGFR) to an existing risk measure can more accurately predict sudden cardiac death (SCD) in patients with congestive heart failure. This new measure of risk,…

Preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2024 suggests that increasing ketone supply to the heart could significantly enhance energy production in cases of heart failure with preserved ejection fraction (HFpEF). HFpEF occurs when there are signs or symptoms of heart failure with a…

Researchers from the Brigham and Women’s Hospital, reporting today in the journal JAMA Cardiology, have found links between patients admitted to the hospital for heart failure and a higher risk of kidney disease. The broad-based study, conducted across 372 participating sites, included adults 65 years and older hospitalized for heart…

Researchers based at the University of East Anglia in the U.K. have confirmed that accounting for biological sex when assessing patients for heart failure improves accuracy of diagnosis. The team behind the work, published in the European Heart Journal Open, fine-tuned a method for diagnosing the condition using magnetic resonance…

Physicians at cancer research and treatment organization City of Hope have published new results from a study that shows the blood vessel relaxing medication carvedilol may benefit childhood cancer survivors who are at risk of developing heart failure. Heart failure developed in later years can be a serious complication for…

Cardiologists and radiation oncologists at Washington University School of Medicine have repurposed radiation therapy, a conventional approach used against cancer, to target patients with ventricular tachycardia. Heart failure, a condition affecting approximately 6.7 million American adults, is characterized by the heart’s gradual loss of its ability to supply the body…

Researchers from the Max Delbrück Center for Molecular Medicine and the Charité University Hospital in Berlin, Germany have uncovered the PDM16 gene as a previously unknown genetic factor that increases the risk of congenital heart failure in women.  Heart failure, characterized by the heart’s inability to pump blood effectively, is…

A clinical study led by scientists at Karolinska Institute and Karolinska University Hospital in Sweden reveals how the hunger hormone ghrelin can increase cardiac pump function in patients with heart failure. According to the Heart Failure Society of America, nearly seven million Americans over the age of 20 suffer from…

Results from a Phase III trial of Australian biotech Mesoblast’s mesenchymal precursor cell therapy for heart failure show improved ejection fraction and lower risk of heart attack or stroke in recipients. However, despite these signs of benefit, the study did not meet its primary endpoint, which was time to recurrent…

A new study published yesterday in JACC: Heart Failure by researchers in China shows that social isolation and loneliness are associated with higher rates of heart failure. However, whether a person feels lonely regardless if they are alone or not is more important in determining risk. The new study helps…